BioSpace News Archive

Business

AbbVie, Anima Strike mRNA Deal Worth Up to $582M

Tuesday, AbbVie partnered with Anima Biotech to discover and develop mRNA modulators in a collaboration of up to $582 million. The partnership will focus on three oncology and immunology targets.

January 10, 2023
·
2 min read
·
Tristan Manalac
Merck Highlights Growth Strategy at J.P. Morgan

The drugmaker’s presentation highlights its strong revenue growth, dominant vaccine business and expanding oncology portfolio.

January 10, 2023
·
3 min read
·
Alex Keown
Business

Amgen Boasts Lucrative Acquisitions, Drug Updates, Burgeoning Biosimilars at JPM

In a presentation led by Robert J. Bradway, Amgen chairman and chief executive officer, the company covered recent acquisitions, Repatha and Lumakras updates, biosimilars and its broader financial outlook.

January 10, 2023
·
2 min read
·
Lisa Munger
Business

Despite Slowdown in COVID, Pfizer Promises Growth

Pfizer forecasts stable growth in the coming years, driven by a strong product push to cushion its non-COVID business and exclusivity losses.

January 10, 2023
·
2 min read
·
Tristan Manalac
Sponsored: Complete Genomics Touts Sequencing Platform, Product Launches at Biotech Showcase

Complete Genomics showcased its innovative sequencing capacity at the Biotech Showcase 2023, one of the year’s most important investor conferences.

January 10, 2023
·
4 min read
·
Editorial Staff
Deals

JPM Day 2: Highlights

Stay on top of what’s happening at JPM. BioSpace is covering all the key announcements all week.

January 10, 2023
·
6 min read
·
BioSpace Staff
Business

Milestone Scientific Announces TEKMIKA as Exclusive STA Single Tooth Anesthesia System® Distributor in Brazil

Milestone Scientific Inc. today announced it has entered into a distribution agreement granting TEKMIKA Health Technologies exclusive distribution rights to market Milestone’s STA Single Tooth Anesthesia System ® (STA) in Brazil.

January 10, 2023
·
4 min read
Motus GI Announces Exploration of Strategic Alternatives to Enhance Shareholder Value and Announces Restructuring Plan

Motus GI Holdings, Inc. announced today it has initiated a process to explore a range of strategic and financing alternatives focused on maximizing stockholder value and accelerating commercialization of the Pure-Vu System.

January 10, 2023
·
4 min read
Business

Veru Announces Appointment of Dr. David D. Ho as Chairman of its Infectious Disease Scientific Advisory Board

Veru Inc. today announced the appointment of David D. Ho, M.D., a trailblazer of infectious disease viral research and therapeutic development, as Chairman of its Scientific Advisory Board (SAB).

January 10, 2023
·
12 min read
Genetown

Agenus to Participate at B Riley Securities’ 2023 Virtual Oncology Conference

Agenus today announced that Dr. Garo Armen, Chairman and CEO of Agenus, and Dr. Steven O’Day, Chief Medical Officer, will participate in a virtual fireside chat at the B Riley Securities’ 2023 Virtual Oncology Conference on Wednesday, January 18th at 11:30am ET.

January 10, 2023
·
1 min read